Filter
56
Text search:
monoclonal
antibodies
Featured
Recommendations
9
New Publications
13
Language
Document type
No document type
21
Guidelines
16
Studies & Reports
8
Manuals
5
Fact sheets
3
Training Material
1
Resource Platforms
1
Strategic & Response Plan
1
Countries / Regions
Global
4
South Africa
3
Congo, Democratic Republic of
2
Pakistan
2
Afghanistan
2
Germany
2
Syria
2
Venezuela
2
Sierra Leone
1
Liberia
1
Nigeria
1
Uganda
1
India
1
Turkey
1
Brazil
1
North Macedonia
1
Western and Central Europe
1
Africa
1
Russia
1
Kazakhstan
1
Vietnam
1
France
1
United Kingdom
1
Portugal
1
Spain
1
Belarus
1
Authors & Publishers
Publication Years
Category
Countries
11
Clinical Guidelines
11
Women & Child Health
6
Public Health
4
Pharmacy & Technologies
4
Capacity Building
1
Key Resources
1
Toolboxes
COVID-19
16
HIV
5
Polio
4
NCDs
4
Rapid Response
2
AMR
2
Planetary Health
2
Pharmacy
2
NTDs
2
Malaria
2
Ebola & Marburg
1
Cholera
1
Natural Hazards
1
Refugee
1
Zika
1
Mental Health
1
BMC Medicine (2015) 13:42 DOI 10.1186/s12916-014-0263-6
The main objectives of the SOPs are to: (i) establish standards and timelines for response activities; and (ii) guide national governments and GPEI partners in key support functions.
This new version of the SOPs presents overall response requirements for dealing with type 1, 2 and 3 poliovirus fo
...
Weekly epidemiological record/ Relevé épidémiologique hebdomadaire 4 AUGUST 2017, 92th YEAR / 4 AOÛT 2017, 417-436
This report presents an analysis of antibacterial agents in preclinical (third annual review) and clinical (fifth annual review) development. The analysis covers traditional (direct-acting small molecules) and non-traditional antibacterial agents in development worldwide. It evaluates to what extent
...
Polio vaccines: WHO position paper – June 2022
recommended
This position paper on polio vaccines replaces the 2016 WHO position paper, and summarizes recent developments in the field.
Responding to a poliovirus event and outbreak, Part 1: General (SOPs) describes the general principles and steps to facilitate timely and effective responses to poliovirus events and outbreaks, and incorporate lessons learned from recent previous outbreak response efforts. This document summarizes r
...
There is no secret to our procedure: the daily scanning of the literature helps us to stay afloat in the never-ending waves of new publications about SARS-CoV-2 and COVID-19. Many papers discussed in the Top 10 will eventually make it into subsequent editions of COVID Reference.
16.7.2021
4th edition
The goal of the strategy is to prevent seasonal influenza, control the spread of influenza from animals to humans, and prepare for the next influenza pandemic.
The new strategy is the most comprehensive and far-reaching that WHO has ever developed for influenza. It outlines a path to protect popul
...
27 September 2022
These WHO interim recommendations for use of the Novavax NVX-CoV2373 vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document and annexes referenced below.
The purpose of this document is to guide clinicians in the care of patients with or at risk of severe illness from influenza virus infection, including those caused by seasonal influenza viruses, pandemic influenza viruses and zoonotic (novel influenza A) viruses.
There is a broad consensus nowadays that the Earth is warming up as a result of greenhouse gas emissions caused by anthropogenic activities. It is also clear that current trends in the fields of energy, development and population growth will lead to continuous and ever more dramatic climate change.
...
